American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines
Abstract
CSFs are recommended in some situations, eg, to reduce the likelihood of febrile neutropenia when the expected incidence is > or = 40%; after documented febrile neutropenia in a prior chemotherapy cycle to avoid infectious complications and maintain dose-intensity in subsequent treatment cycles w …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
clinical trials as topic
humans
pubmed abstract
nih
national institutes of health
national library of medicine
adult
Child
Comparative Study
Medical*
United States
practice guideline
guideline
societies
drug-related side effects and adverse reactions
neoplasms / therapy
pmid:7964965
doi:10.1200/jco.1994.12.11.2471
colony-stimulating factors / adverse effects
colony-stimulating factors / economics
colony-stimulating factors / therapeutic use*
medical oncology*
Access
Citation
ID:
116044
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
116044
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet